Sanofi, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), bought 135,650 shares at $473.88 ($64.9M) on 2017-06-02, disclosed to the SEC on 2017-06-06.
Open-market purchase of $64.9M REGN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $466.38 | 402 | $187K | 0.3% |
| 2 | $469.81 | 2,132 | $1.0M | 1.5% |
| 3 | $470.72 | 13,544 | $6.4M | 9.8% |
| 4 | $471.82 | 7,443 | $3.5M | 5.4% |
| 5 | $473.07 | 5,806 | $2.7M | 4.2% |
| 6 | $473.88 | 7,068 |
| $3.3M |
| 5.2% |
| 7 | $475.16 | 12,020 | $5.7M | 8.8% |
| 8 | $476.15 | 6,312 | $3.0M | 4.6% |
| 9 | $478.94 | 6,507 | $3.1M | 4.8% |
| 10 | $480.17 | 12,710 | $6.1M | 9.4% |
| 11 | $481.13 | 15,197 | $7.3M | 11.3% |
| 12 | $482.08 | 23,490 | $11.3M | 17.5% |
| 13 | $483.04 | 18,311 | $8.8M | 13.6% |
| 14 | $484.04 | 4,708 | $2.3M | 3.5% |
| Total | $478.20 avg | 135,650 | $64.9M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |